Formation of experimental murine AA amyloid fibrils in SAP-deficient mice: High resolution ultrastructural study

Amyloid

Volumn 12, Issue 3, 2005, Pages 157-163

  Inoue, Sadayuki ^a   Kawano, Hiroo ^b   Ishihara, Tokuhiro ^b   Maeda, Shuichiro ^c   Ohno, Shinichi ^c  

^a MCGILL UNIVERSITY   (Canada)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

AA amyloid; Amyloid fibrils; Chondroitin sulfate proteoglycan; SAP deficient mice; Serum amyloid P component; Ultrastructure

Indexed keywords

AMYLOID; CONGO RED; PROTEOCHONDROITIN SULFATE; PROTEOHEPARAN SULFATE; SERUM AMYLOID P;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FIBER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN STRUCTURE; ULTRASTRUCTURE; WILD TYPE;

AMYLOID; AMYLOIDOSIS; ANIMALS; DISEASE MODELS, ANIMAL; MICE; MICE, KNOCKOUT; SERUM AMYLOID P-COMPONENT; SPLEEN;

EID: 27144442080     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120500232010     Document Type: Article

References (24)

1. Togashi S, Lim S-K, Kawano H, Ito S, Ishihara T, Okada Y, Nakano S, Kinoshita T, Horie K, Episkopou V, et al. Serum amyloid P component enhances induction of murine amyloidosis. Lab Invest 1997;77:525-531.
2. Kisilevsky R, Young ID. Pathogenesis of amyloidosis. In: Husby G, editor. Clinical rheumatology: Reactive amyloidosis and the acute phase response. Vol. 8, London: Bailliere Tindall; 1994. pp 613-626.
3. Kisilevsky R, Gruys E, Shirahama T. Does amyloid enhancing factor (AEF) exist? Is AEF a single biological entity? Amyloid: J Protein Folding Disord 1995;2:128-133.
4. Inoue S, Kisilevsky R. A high resolution ultrastructural study of experimental murine AA amyloid. Lab Invest 1996;74: 670-683.
5. Inoue S, Kisilevsky R. In situ electron microscopy of amyloid deposits in tissues. Methods Enzymol 1999;309: 496-509.
6. Inoue S, Kuroiwa M, Tan R, Kisilevsky R. A high resolution ultrastructural comparison of isolated and in situ murine AA amyloid fibrils. Amyloid: Int J Exp Clin Invest 1998;5: 99-110.
7. Inoue S, Kuroiwa M, Kisilevsky R. AA protein in experimental murine AA amyloid fibrils: A high resolution ultrastructural and immunohistochemical study comparing aldehyde-fixed and cryofixed tissues. Amyloid: J Protein Folding Disord 2002;9:115-125.
8. Usui I, Kawano H, Ito S, Hamada Y, Ishihara T, Maeda S. Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits. Amyloid: J Protein Folding Disord 2001;8:101-104.
9. Ram JS, DeLellis RA, Glenner GG. Amyloid III: A method for rapid induction of amyloidosis in mice. Int Arch Allergy 1968;34:201-204.
10. Kohno K, Palha JA, Miyakawa K, Saraiva MJM, Ito S, Mabuchi T, Blaner WS, Iijima H, Tsukahara S, Episkopou V, et al. Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy. Am J Pathol 1997;150:1497-1508.
11. Takeda M, Takayama I, Terada N, Baba T, Ward SM, Ohno S, Fijino MA. Immunoelectron-microscopic study of Kit-expressing cells in the jejunum of wildtype and Ws/Ws rats. Cell Tissue Res 2001;304:21-30.
12. Inoue S. Ultrastructural organization of connective tissue microfibrils in the posterior chamber of the eye in vivo and in vitro. Cell Tissue Res 1995;279:291-302.
13. Inoue S, Kuroiwa M, Kisilevsky R. Basement membrane, microfibrils and β-amyloid fibrillogenesis in Alzheimer's disease: high resolution ultrastructural findings. Brain Res Rev 1999;29:218-231.
14. Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962;10:355-364.
15. Romhányi G. Selective differentiation between amyloid and connective tissue structures based on the collagen-specific topo-optical staining reaction with Congo red. Virchows Arch (Pathol Anat) 1971;354:209-222.
16. Wolman M, Bubis JJ. The cause of the green polarization color of amyloid stained with Congo red. Histochemie 1965; 4:351-356.
17. Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson CM. Designing conditions for in vitro formation of amyloid protofibrils and fibrils. Proc Natl Acad Sci USA 1999;96:3590-3594.
18. 2-microglobulin amyloid fibrils. Kidney Int 1997;52: 1543-1549.
19. Inoue S, Hultin PG, Szarek WA, Kisilevsky R. Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study. Lab Invest 1996;74:1081-1090.
20. Pepys MB, Dyck RF, de Beer FC, Skinner M, Cohen AS. Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol 1979;38:284-293.
21. Tennent GA, Lovat LB, Pepys MB. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer's disease and systemic amyloidosis. Proc Natl Acad Sci USA 1995;92:4299-4303.
22. Holm Nielsen E, Nybo M, Junker K, Toftedal Hansen P, Rasmussen IM, Svehag S-E. Localization of human serum amyloid AP component and heparan sulfate proteoglycan in in vitro-formed Aβ fibrils. Scand J Immunol 2000;52: 110-112.
23. McCubbin WD, Kay CM, Narindrasorasak S, Kisilevsky R. Circular dichroism and fluorescence studies on two murine serum amyloid A proteins. Biochem J 1988;256: 775-783.
24. De Beer MC, De Beer FC, McCubbin WD, Kay CM, Kindy MS. Structural prerequisites for serum amyloid A fibril formation. J Biol Chem 1993;268:20606-20612.